Contribution of magnetic particles in molecular diagnosis of human viruses.

Detection Enrichment Extraction Magnetic nanoparticles Viruses

Journal

Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R

Informations de publication

Date de publication:
01 May 2022
Historique:
received: 16 12 2021
revised: 17 01 2022
accepted: 18 01 2022
pubmed: 6 2 2022
medline: 22 2 2022
entrez: 5 2 2022
Statut: ppublish

Résumé

Viral diseases are the primary source of death, making a worldwide influence on healthcare, social, and economic development. Thus, diagnosis is the vital approach to the main aim of virus control and elimination. On the other hand, the prompt advancement of nanotechnology in the field of medicine possesses the probability of being beneficial to diagnose infections normally in labs as well as specifically. Nanoparticles are efficiently in use to make novel strategies because of permitting analysis at cellular in addition to the molecular scale. Henceforth, they assist towards pronounced progress concerning molecular analysis at the nanoscale. In recent times, magnetic nanoparticles conjugated through covalent bonds to bioanalytes for instance peptides, antibodies, nucleic acids, plus proteins are established like nanoprobes aimed at molecular recognition. These modified magnetic nanoparticles could offer a simple fast approach for extraction, purification, enrichment/concentration, besides viruses' recognition precisely also specifically. In consideration of the above, herein insight and outlook into the limitations of conventional methods and numerous roles played by magnetic nanoparticles to extract, purify, concentrate, and additionally in developing a diagnostic regime for viral outbreaks to combat viruses especially the ongoing novel coronavirus (COVID-19).

Identifiants

pubmed: 35121538
pii: S0039-9140(22)00039-X
doi: 10.1016/j.talanta.2022.123243
pmc: PMC8779935
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123243

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Références

Biosens Bioelectron. 2019 Sep 15;141:111351
pubmed: 31176113
ACS Nano. 2015 Mar 24;9(3):3184-91
pubmed: 25743636
J Clin Microbiol. 2003 Aug;41(8):3532-6
pubmed: 12904351
Anal Chem. 2019 Oct 1;91(19):12238-12245
pubmed: 31513379
Int J Mol Sci. 2013 Oct 25;14(11):21266-305
pubmed: 24232575
ACS Appl Mater Interfaces. 2015 Jun 3;7(21):11215-23
pubmed: 25970703
Methods Mol Biol. 2019;1885:309-323
pubmed: 30506207
Expert Rev Anti Infect Ther. 2015 Aug;13(8):939-46
pubmed: 26091780
Nanomedicine (Lond). 2020 Sep;15(21):2085-2102
pubmed: 32723142
J Pharm Investig. 2018;48(1):43-60
pubmed: 30546919
Sensors (Basel). 2021 Jul 28;21(15):
pubmed: 34372350
Nanomedicine. 2007 Mar;3(1):95-101
pubmed: 17379174
Ther Adv Infect Dis. 2017 Jul;4(4):105-131
pubmed: 28748089
Front Immunol. 2019 Jan 24;10:22
pubmed: 30733717
Diagnostics (Basel). 2019 Jul 11;9(3):
pubmed: 31336721
J Nat Med. 2018 Jan;72(1):32-42
pubmed: 29164507
Expert Rev Anti Infect Ther. 2022 Oct;20(10):1299-1308
pubmed: 33164589
Ann Clin Biochem. 2020 Jul;57(4):274-276
pubmed: 32343598
Nanotheranostics. 2017 Jun 9;1(3):244-260
pubmed: 29071191
Anal Chem. 2014 Jun 17;86(12):5682-7
pubmed: 24909945
Clin Chim Acta. 2020 Jun;505:172-175
pubmed: 32156607
Biosens Bioelectron. 2018 Apr 15;102:425-431
pubmed: 29175218
Int J Microbiol. 2020 Sep 4;2020:8832728
pubmed: 32908530
J Nanosci Nanotechnol. 2008 Jan;8(1):293-300
pubmed: 18468073
Biosens Bioelectron. 2016 Mar 15;77:603-8
pubmed: 26479905
J Nanobiotechnology. 2020 Apr 21;18(1):62
pubmed: 32316985
Nano Lett. 2008 Oct;8(10):3423-8
pubmed: 18754596
Biomater Sci. 2016 Dec 20;5(1):57-66
pubmed: 27845789
Food Microbiol. 2019 Dec;84:103236
pubmed: 31421754
ACS Appl Mater Interfaces. 2017 Nov 22;9(46):39953-39961
pubmed: 29088538
J Clin Lab Anal. 2007;21(4):244-8
pubmed: 17621359
Int J Nanomedicine. 2021 Jan 26;16:623-649
pubmed: 33531805
Molecules. 2011 Oct 24;16(10):8894-918
pubmed: 22024958
Angew Chem Int Ed Engl. 2009;48(15):2764-7
pubmed: 19288507
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
Emergent Mater. 2021;4(1):131-141
pubmed: 33554045
Anal Chim Acta. 2020 May 1;1109:148-157
pubmed: 32252898
J Biomed Nanotechnol. 2017 Dec 1;13(12):1619-1630
pubmed: 29490751
J Biomed Nanotechnol. 2016 Apr;12(4):710-6
pubmed: 27301197
Front Chem. 2017 Oct 31;5:80
pubmed: 29164100
Nat Biotechnol. 2002 Aug;20(8):816-20
pubmed: 12134166
Appl Phys A Mater Sci Process. 2021;127(12):960
pubmed: 34866806
Diagn Microbiol Infect Dis. 2007 Jul;58(3):333-5
pubmed: 17376631
J Am Chem Soc. 2003 Aug 27;125(34):10192-3
pubmed: 12926940
Vaccines (Basel). 2020 Oct 01;8(4):
pubmed: 33019545
Angew Chem Int Ed Engl. 2009;48(9):1620-4
pubmed: 19156803
Appl Microbiol Biotechnol. 2006 Dec;73(3):495-504
pubmed: 17063328
Eur J Pharm Sci. 2020 Oct 1;153:105465
pubmed: 32668312
Front Chem. 2018 Aug 20;6:360
pubmed: 30177965
Biosensors (Basel). 2018 Feb 26;8(1):
pubmed: 29495424
Nature. 2015 May 21;521(7552):362-5
pubmed: 25901685
Front Immunol. 2019 Jan 22;9:3071
pubmed: 30723475
Sci Rep. 2020 Nov 4;10(1):19004
pubmed: 33149153
Sci Rep. 2017 Mar 23;7:45199
pubmed: 28332631
ACS Appl Mater Interfaces. 2019 Feb 13;11(6):5762-5770
pubmed: 30688060
Hum Vaccin. 2011 Jun;7(6):685-93
pubmed: 21508676
Nanomedicine (Lond). 2010 Feb;5(2):269-85
pubmed: 20148638
Transfusion. 2005 Jul;45(7):1106-10
pubmed: 15987354
Trends Analyt Chem. 2017 Dec;97:445-457
pubmed: 32287543
Biosens Bioelectron. 2017 Jan 15;87:679-685
pubmed: 27631682
Front Bioeng Biotechnol. 2020 Feb 20;8:102
pubmed: 32154233
Biol Methods Protoc. 2020 Oct 08;6(1):bpaa020
pubmed: 33628946
Int J Environ Res Public Health. 2019 Aug 30;16(17):
pubmed: 31480254
Sensors (Basel). 2015 Apr 27;15(5):9915-27
pubmed: 25923937
Biosens Bioelectron. 2016 Nov 15;85:503-508
pubmed: 27209577
Indian J Tuberc. 2020 Dec;67(4S):S163-S166
pubmed: 33308664
Clin Microbiol Rev. 2012 Apr;25(2):344-61
pubmed: 22491775
Asian J Pharm Sci. 2021 Nov;16(6):704-737
pubmed: 35027950
Biosens Bioelectron. 2015 Dec 15;74:134-41
pubmed: 26134291
Heliyon. 2018 Mar 14;4(3):e00572
pubmed: 29556569
Nanoscale Adv. 2020 May 19;2(7):3017-3026
pubmed: 36132417
Molecules. 2015 Aug 03;20(8):14051-81
pubmed: 26247927
BMC Vet Res. 2019 Jan 17;15(1):30
pubmed: 30654823
Vet World. 2016 May;9(5):465-9
pubmed: 27284221
Glob Chall. 2021 Feb 22;5(4):2000068
pubmed: 33786197
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Sens Actuators B Chem. 2020 Oct 15;321:128494
pubmed: 32834503
Biomaterials. 2017 Aug;136:98-114
pubmed: 28525855
Methods Mol Biol. 2020;2099:99-106
pubmed: 31883090
PLoS Biol. 2019 Jan 10;17(1):e3000107
pubmed: 30629605
ACS Appl Mater Interfaces. 2018 Apr 18;10(15):12534-12543
pubmed: 29595253
J Nanosci Nanotechnol. 2017 Jan;17(1):802-06
pubmed: 29634167
Nanomedicine. 2019 Jun;18:196-220
pubmed: 30904587
Mater Sci Energy Technol. 2020;3:237-249
pubmed: 33604529
J Immunol Methods. 1985 Mar 18;77(2):297-304
pubmed: 3920326
J Vis Exp. 2017 Nov 9;(129):
pubmed: 29155773
Bioengineered. 2013 Jan-Feb;4(1):9-14
pubmed: 22922205
ACS Sens. 2021 Mar 26;6(3):976-984
pubmed: 33496572

Auteurs

Sumera Khizar (S)

Univ Lyon, Université Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, F-69622, Lyon, France.

Amal A Al-Dossary (AA)

Department of Basic Sciences, Deanship of Preparatory Year and Supporting Studies, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam, 34212, Saudi Arabia.

Nadia Zine (N)

Univ Lyon, Université Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, F-69622, Lyon, France.

Nicole Jaffrezic-Renault (N)

Univ Lyon, Université Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, F-69622, Lyon, France.

Abdelhamid Errachid (A)

Univ Lyon, Université Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, F-69622, Lyon, France.

Abdelhamid Elaissari (A)

Univ Lyon, Université Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, F-69622, Lyon, France. Electronic address: abdelhamid.elaissari@univ-lyon1.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH